Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency
about
Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of actionAn in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathwayDramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibilityInteraction between cholesteryl ester transfer protein and hepatic lipase encoding genes and the risk of type 2 diabetes: results from the Telde study.Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adultsMolecular regulation of HDL metabolism and function: implications for novel therapies.Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiencyHuman ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic miceRegulation of Hepatic Cholesteryl Ester Transfer Protein Expression and Reverse Cholesterol Transport by Inhibition of DNA Topoisomerase IIThematic review series: patient-oriented research. What have we learned about HDL metabolism from kinetics studies in humans?Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules.Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner.Proteolysis of apolipoprotein A-I by secretory phospholipase A₂: a new link between inflammation and atherosclerosisIn vivo kinetic studies to further understand pathogenesis of abnormal lipoprotein metabolism in chronic kidney disease.The potential of cholesteryl ester transfer protein as a therapeutic target.Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits.Dual effects on HDL metabolism by cholesteryl ester transfer protein inhibition in HepG2 cells.The fate of HDL particles in vivo after SR-BI-mediated selective lipid uptake.Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism.Effect of the cholesteryl ester transfer protein genotypes on plasma lipid and lipoprotein levels in Vietnamese children.Particle number analysis of lipoprotein subclasses by gel permeation HPLC in patients with cholesteryl ester transfer protein deficiency.HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics.Trials and Tribulations of CETP Inhibitors.Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency.High-density lipoprotein subfractions and influence of endothelial lipase in a healthy Turkish population: a study in a land of low high-density lipoprotein cholesterol.
P2860
Q28285064-F59414E7-7F5E-473D-87BB-B1E4486D2718Q28540807-3F7F848C-BA8F-4B26-819F-AFDB2BED9B85Q28586230-F5A35B56-0548-43BA-A7FE-E31DF4A41328Q34071859-05D26034-6EC2-4990-A517-92BF21B13685Q34823459-C4608696-6FD7-43D3-A8ED-B8D4B1F09153Q35191066-283F7D2A-62E9-43A2-9AE8-C28BDB699B66Q35590298-9F79FD97-EE86-4F57-AA03-17431055148CQ35763409-BFAE934C-CE27-422B-8CB9-77F211652475Q35824669-EE5C9AF2-4C49-46DB-896E-8674287E4583Q35860767-D755D9BC-4500-4647-9083-A37CC4D5BBB7Q36473656-28A13777-BC3E-4A66-815C-8FA944B92A83Q36957089-984030BE-C380-46DC-A483-772E5F9D1A8FQ37013499-5EFAF59A-91FC-46A6-8CA6-400F725114E4Q37354180-26D922E7-005B-4B03-808A-DE2E635DDB39Q37683292-EDEE2E67-2A57-480A-A931-7A85E17FFD35Q38152962-76B3491D-6B04-4C9E-B260-8589836AED83Q38554684-0A6F7068-6ABC-48F8-960C-619186A4C685Q40166036-0EB052C0-7B5A-4F41-97C9-9EA885BA6AA3Q40668441-43F52B90-2DAD-45DD-A579-F186BBD90BDAQ40694088-78FC1E07-0F9C-418D-A155-F353859252C5Q41571785-E6A364B8-690F-47B2-B2C9-13B510A1B6B8Q46818505-C815EBF5-552D-43BC-8F1E-AEBB417B9DAEQ47229897-DF249ABE-BA8E-4653-863B-8573F00B943DQ47657807-E13BB701-CA9F-4223-BE15-72A08F044A52Q47669381-13E6A6F6-5B02-469B-929E-ECC63E244756Q47717901-F61F117E-2D35-42E5-93BF-FE76311C05A6Q51164566-E373CFA3-6D3E-49E0-9300-E1B6FF92211C
P2860
Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency
description
1993 nî lūn-bûn
@nan
1993 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Delayed catabolism of high den ...... er transfer protein deficiency
@ast
Delayed catabolism of high den ...... er transfer protein deficiency
@en
type
label
Delayed catabolism of high den ...... er transfer protein deficiency
@ast
Delayed catabolism of high den ...... er transfer protein deficiency
@en
prefLabel
Delayed catabolism of high den ...... er transfer protein deficiency
@ast
Delayed catabolism of high den ...... er transfer protein deficiency
@en
P2093
P2860
P356
P1476
Delayed catabolism of high den ...... er transfer protein deficiency
@en
P2093
Fairwell T
Ishikawa T
Nakamura H
Nishiwaki M
Sakamoto T
Schaefer JR
Wakimoto N
P2860
P304
P356
10.1172/JCI116750
P407
P577
1993-10-01T00:00:00Z